Navigation Links
Elsevier Appoints New President of Elsevier CPM Resource Center
Date:4/30/2012

GRAND RAPIDS, Michigan, April 30, 2012 /PRNewswire/ --


Hajo Oltmanns to lead expansion of CPM's clinical decision support tools


Elsevier, a world-leading provider of scientific, technical and medical information products and services, has appointed Hajo Oltmanns as the new President of Elsevier CPM Resource Center (CPM), a leader in developing clinical decision support (CDS) tools for healthcare.

Hajo will lead the continued development and expansion of CPM's clinical decision support tools and the engagement of the CPM International Consortium, an organization composed of hundreds of CPM's client hospitals and health systems. Hajo is also responsible for the development of Elsevier's new Order Sets, which is expected to launch in late 2012. 

Hajo's appointment comes as CPM and our other CDS groups work together to transform healthcare," said Jay Katzen, Managing Director, Elsevier Clinical Decision Support and Payer Solutions. "Hajo's experience and understanding of healthcare will help grow this business, empowering our customers to achieve measureable, sustainable success through the implementation of evidence-based CDS and professional practice expertise."

At Elsevier Health Sciences, Hajo previously served as the Senior Vice President of Strategy & Business Development, focusing on the CDS group. Hajo joined Elsevier in 2007 and served as a member of the executive strategy team, working across all international businesses units while based in Amsterdam.

Prior to Elsevier, Hajo was a manager at the Boston Consulting Group in Chicago, where he focused on strategy, development and customer understanding across several industries, including healthcare.

Originally from Germany, Hajo has an MA from the University of Edinburgh and an MBA from Northwestern University's Kellogg School of Management.

About Elsevier


Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Mosby's Nursing Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.


A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Tom Reller
Vice President, Global Corporate Relations, Elsevier
+1-215-239-3508
t.reller@Elsevier.com



'/>"/>
SOURCE Elsevier
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Elsevier Launches New Journal: Journal of Applied Research in Memory and Cognition
2. Elsevier Launches New Journal: Journal of Obsessive-Compulsive and Related Disorders
3. Elsevier Integrates its Clinical Decision Support Solutions Into PatientKeeper CPOE
4. Elsevier Introduces Expert Discovery Application for SciVerse Hub
5. Elsevier Honored With Six PROSE Awards
6. Elsevier and OpenHelix Release Tutorial Suites for SciVerse Applications
7. Elsevier and Leidens Scaliger Institute Establish Fellowship Program for Rare Books Scholars
8. Elsevier Announces Two Tetrahedron Symposia for 2012
9. New Stage of Scientific Development for St.Petersburg State University Marked by Signed Agreement With Elsevier
10. Elsevier and the Fulbright Commission Honor UK Research Talent With the UK Scopus Young Researcher Award
11. Elseviers BrainNavigator 3.2 Offers New Functionality to Speed Neurological Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... , Oct. 12, 2017 AVACEN Medical , ... company with their  2017 New Product Innovation Award for ... extensive primary and secondary medical device market research by Frost ... its first-to-market OTC, drug-free pain relief product, the AVACEN 100, ... to treating fibromyalgia widespread pain. ...
(Date:10/11/2017)...  True Health, a leader in integrated diagnostics ... National Breast Cancer Awareness month to educate doctors ... Research recently published in ... than 10 million American women are at significant ... BRCA2 and have not had testing. These mutations can ...
(Date:10/5/2017)... 2017  In response to the nationwide opioid ... Surgeons (AAOMS) released prescribing recommendations that urge ibuprofen ... as a first-line therapy to manage a patient,s ... Recognizing the value and importance of ... Prescribing: Acute and Postoperative Pain Management" stresses that ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading Health and Nutrition ... the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing CBD market ... can be easily incorporated into liquid products, while reducing costs to end users. , ...
(Date:10/13/2017)... N.J. (PRWEB) , ... October 13, 2017 , ... The ... Holly Day Market. Featuring a collection of specialty vendors and unique items from across ... personalized and quality-focused health and wellness services offered by the VNA. The boutique ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, ... Development, has been awarded a contract by the Center for Medicare and Medicaid ... to accelerate the enterprise use of Agile methodologies in a consistent and high ...
(Date:10/12/2017)... Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... centers in the U.S., announced today its plans to open a flagship location in ... will occupy the former Rooms To Go store next to Office Depot in the ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
Breaking Medicine News(10 mins):